2015
DOI: 10.1016/j.ijpharm.2014.10.057
|View full text |Cite
|
Sign up to set email alerts
|

Electrospun polyurethane/Eudragit ® L100-55 composite mats for the pH dependent release of paclitaxel on duodenal stent cover application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
30
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 49 publications
(32 citation statements)
references
References 24 publications
2
30
0
Order By: Relevance
“…The premise of pH change in the duodenum can be exploited for the treatment by using the acidic pH as the drug release trigger for BTZ into the target tumor 30 . Also, one example of a pH gradient inside the body is in the duodenum.…”
Section: Resultsmentioning
confidence: 99%
“…The premise of pH change in the duodenum can be exploited for the treatment by using the acidic pH as the drug release trigger for BTZ into the target tumor 30 . Also, one example of a pH gradient inside the body is in the duodenum.…”
Section: Resultsmentioning
confidence: 99%
“…49 Electrospun PU-dextran nanofibre mats have been loaded with estradiol (the most bioactive endogenous estrogen) to improve cutaneous wound repair in post-menopausal women; 50 the electrospinning process directly blends the PU and dextran polymers to obtain the optimum physical and biological properties of the fibres. Electrospinning was also used to make a nanofibre composite PU-Eudragit acrylic polymer mat in which the pH dependent release of paclitaxel was investigated; 51 the acrylic polymer allowed release of the drug in the duodenum (mean pH 5.4). Smart sensitive polymers, designed to change properties based of environmental conditions (pH sensitive in this case), have been prepared from PU-N,N-diethylaminoethyl methacrylate hybrids, with rhodamine 6G added as a model drug; 52 loading methods and release mechanisms were discussed.…”
Section: Drug Delivery Vehiclesmentioning
confidence: 99%
“…Various examples of monolithic or blended nanofibers that can or cannot delay drug release can be found in the literature (68,(95)(96)(97), and although some gastro-resistant coreshell nanofibers have been developed (91,93), they are not a general solution for all drugs (92). Thus, delayed release does not depend only on the composition, structure, presence of drug on the nanofiber surface, or defects in the shell of the nanofibers, but also on the drug properties, including its solubility at low pH, molecular weight, and interactions with the polymer (18,68,92,(95)(96)(97).…”
Section: Delayed Drug Releasementioning
confidence: 99%